
La Roche-Posay Retinol B3 Pure Retinol Serum Review
BLC Research Score
A research-based assessment from ingredient and formula analysis plus reputation, not a hands-on lab test. See our scoring approach.
- Best for
- sensitive
- Price
- $44.99 / 1 fl oz (30ml)
- Main claim
- Anti-aging firming
- Texture
- Lightweight, hydrating texture.
Editorial pick only.
Quick verdict
La Roche-Posay Retinol B3 Pure Retinol Serum sits in the mid-range tier at $44.99 for 1 fl oz (30ml). Best for sensitive skin.
Key ingredients
What the hero actives in Retinol B3 Pure Retinol Serum are supposed to do.
Primary
Pure Retinol
Supporting
Niacinamide, Hyaluronic Acid, Glycerin, Dimethicone
Learn more about these actives
Hyaluronic Acid
A humectant that binds up to 1000x its weight in water, plumping skin and softening the appearance of fine lines.
Read the full Hyaluronic Acid guide ->Niacinamide
A multi-tasking vitamin B3 derivative that reduces pore appearance, calms redness, brightens uneven tone, and strengthens the skin barrier.
Read the full Niacinamide guide ->Glycerin
The most foundational humectant in skincare. Pulls water into the upper layers of skin and strengthens the skin barrier.
Read the full Glycerin guide ->Alternatives to La Roche-Posay Retinol B3 Pure Retinol Serum
Other face serums we have reviewed.
ALASTIN
C-RADICAL Defense Antioxidant Serum
$218.00 / Full size
Read review ->ALASTIN
A-LUMINATE Brightening Serum
$198.00 / Full size
Read review ->Anua
Niacinamide 10 TXA 4 Serum
$24.00 / 1.01 fl oz (30ml)
Read review ->Anua
PDRN Hyaluronic Acid Capsule 100 Serum
$30.00 / 1.01 fl oz (30ml)
Read review ->See category roundups:
Final verdict
La Roche-Posay Retinol B3 Pure Retinol Serum is a mid-range face serum for sensitive skin.
Check price at LaIndependent. No sponsored placement.
Comparing options? See all our tested picks on the BestLiftingCream.com homepage.
Editor's note
Reviewed by the BLC Editorial Team using our standardized 7-criteria scoring methodology. Independent and not sponsored.
Last updated: Sep 29, 2026. Read how we evaluate.